New incident report
Incident Report Number: 2020-2255
Registrant Reference Number: 2019-CA-000016
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: CANADA
Prov / State: NOVA SCOTIA
PMRA Registration No. 30731 PMRA Submission No. EPA Registration No.
Product Name: Hartz UltraGuard Pro Drops for Dogs Over 28 kg Spot-on
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Animal's Owner
Dog / Chien
German Shepherd
1
Female
0.75
100
lbs
Skin
Unknown / Inconnu
<=30 min / <=30 min
System
>3 days <=1 wk / >3 jours <=1 sem
No
No
Fully Recovered / Complètement rétabli
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 03-May-2019, a 9 month old, 100 pound, female, Shepherd Dog - German dog, in unknown condition, with no known concomitant medical condition, was administered 1 tube of Hartz UltraGuard Pro Drops for Dogs Over 28 kg (Phenothrin / S Methoprene) via the topical route by the animal owner. The product was applied between the shoulder blades along the dog's back to the base of the tail. Approximately fifteen seconds post application, the dog developed agitation, application site pruritus and began rolling on the ground. The animal owner wiped the application site using a wet rag and the symptoms slightly improved but continued. Approximately 10 minutes post application, the dog developed lethargy, anorexia and was reluctant to be touched at the application site. The symptoms of lethargy and anorexia resolved approximately 12 hours post onset. On approximately 06-May-2019, the dog allowed the animal owner to touch her and they discovered small, red bumps on the application site. On approximately 10-May-2019, the symptoms resolved and the dog recovered. Bathing with liquid dish soap was discussed as an option if the owner wished to remove the product. Recommended consulting with a veterinarian and discontinue use of the product in the future. No further information was received in this case.
Minor
This product has a wide margin of safety but with this active ingredient we can see lethargy, agitation, gastrointestinal upset, and pruritis. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.